Breaking News, Financial News

Financial Report: BASi

Service revenues up 14% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BASi 3Q Revenues: $6.0 million (+8%) 3Q Earnings: $215,000 (-63%) YTD Revenues: $18.2 million (+10%) YTD Loss: $666,000 (earnings were $521 million YTD13) Comments: Service revenue in the quarter increased 14% to $4.8 million primarily due to higher toxicology revenue, offset slightly by lower bioanalytical analysis revenue. Product revenue decreased 12% to $1.3 million. Earnings in the quarter and YTD were affected by non-cash decreases in the fair value of warrant liability of $66,000 and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters